ER injection aims to stop repeat asthma crises
NCT ID NCT06705764
Summary
This study is testing if a new monthly injection called Tezepelumab, given right in the Emergency Room, can help control severe asthma attacks and prevent people from needing to return to the ER. It will compare the injection to a placebo in 100 adults with severe asthma who come to the ER with an attack. The main goal is to see if the treatment reduces return ER visits and the need for steroid medications over 90 days.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sturgeon Community Hospital
St. Albert, Alberta, T8N6C4, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Alberta
Edmonton, Ca-ab, T6G 2G3, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.